Core Viewpoint - MicroPort Medical (00853) anticipates turning a profit by the end of the fiscal year ending December 31, 2025, with a projected net profit of no less than $20 million, recovering from an audited net loss of approximately $268 million for the fiscal year ending December 31, 2024 [1] Group 1: Financial Performance - The expected turnaround to profitability is primarily attributed to continuous revenue growth, particularly from overseas operations, which are projected to contribute to a year-on-year increase of approximately 70% [1] - Despite downward pressure on product prices due to domestic industry policies in China, the implementation of cost optimization measures is expected to result in a gross margin improvement of 2-3 percentage points year-on-year [1] Group 2: Operational Efficiency - The company is focusing on deepening lean management practices to enhance operational efficiency, leading to a year-on-year decrease in operating expenses of approximately 10-11% [1] - The disposal of subsidiaries is also expected to contribute positively to the company's overall financial performance [1]
微创医疗发盈喜 预期2025年度取得净利润不低于2000万美元 同比扭亏为盈